EUROIMMUN CEO Interviewed by Clinical Lab Products in regard to Zika virus

May 28, 2016 | News

EUROIMMUN US CEO Hamid Erfanian was interviewed by Steve Halasey editor of Clinical Lab Products magazine. Use the link below to read the full article.

EUROIMMUN CEO Interviewed by Clinical Lab Products in regard to Zika virus

News

Recent News

ABC News: Largest antibody study could answer crucial coronavirus questions

Membranous Nephropathy: Antibody-based diagnosis, prognosis, and disease monitoring

EUROIMMUN Announces Option Agreement with Roche on Zika Virus Serology

EUROIMMUN CEO Interviewed by Clinical Lab Products in regard to Zika virus

Euroimmun US News

Euroimmun Unveils New Visual Identity at ADLM 2025

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

Oropouche Virus Disease Among U.S. Travelers – United States, 2024

The subsidiary ProciseDx announces distribution agreement with Revvity’s EUROIMMUN US for the distribution of the ProciseDx platform in the United State and Canada

Contact Us

Follow Us